Cytochemistry i

8,579 views 48 slides Oct 05, 2020
Slide 1
Slide 1 of 48
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48

About This Presentation

Cytochemistry i


Slide Content

Rabab Salama
Clinical and Chemical Pathology Consultant,
HCQM Specialist
1

Diagnostic tools in hematology
1.Routine stain& morphology
2.Cytochemistry
3.Immunophenotyping
4.Cytogenetics
5.Molecular biology
2

Study of chemical elements in
cells.
3

4

Substrate +Enzyme >>>>Product
+
Visible product <<<<Chromogen
5

Components of Cytochemistry
Fixative
Buffer
Substrate
Chromogen (dye)
Counterstain
6

Fixatives
Types:
Methanol, ethanol, acetone, formation vapor,
formaldehyde, formal acetone, formal
ethanol
7

Factors Affecting Fixation
1.Timing
Most fixatives 5-7 min
MPO: 15 sec
LAP: 30 sec
1.Type of fixative
2.Temperature
At room temperature (LAP, SBB) –at 4°C
(MPO, estate, LAP)
8

Buffers
pH
Molarity
Time
Temperature
Factors Affecting Buffers:
9

Counterstains
MPO
Mayer's Hematoxylin
SBB
nuclear counterstain: 1% Aqueous cresol
violet
Background stain: 0.2% aqueous light green +
2 drops glacial AA
10

Control
Internal control
Cells in BM known to be positive for the stain
External control
Normal blood smear containing neutrophils,
lymphocytes and monotypes (eg. PAS, LAP)
Slide from patient to have the disease 11

Types of specimens
Peripheral blood.
Bone marrow aspirated and imprints.
Paraffin section from bone marrow biopsy.
Aspirated and imprints of LN, spleen.
Fresh samples to ensure optimal enzyme activity
Smears from non-enzymatic stains as PAS and
SBB stains may remain stable for months.
12

Control slides do not exhibit proper
staining pattern?
Reagents:
Expiry date
Contamination
Procedures:
Steps not followed correctly
Smear:
Age of the slide.
Storage: some enzymes diminish in activity over time
(fresh samples)
13

Types
Myeloperoxidase (MPO)
Leukocyte Alkaline Phosphates (LAP or NAP)
Acid Phosphates, TRAP
Estrase
Sudan Black B stain (SBB)
Iron stain
Reticulinstain
Periodic Acid Schiff (PAS)
14

PEROXIDASE STAIN
Purpose:
Todifferentiateamyelogenousormonocytic
leukemiafromacutelymphocyticleukemia.
Peroxidaseispresentintheprimaryazurophilic
granulesofneutrophil,eosinophilandmonocyte&
activityincreasedwithmaturation,noactivityis
foundinredcellsorlymphocytes.
15

16

PEROXIDASE STAIN
Principle:
Inthepresenceofmyeloperoxidase,H2O2oxidizes
substrate(benzedineorDAB)formingblackppt.
17

Reagents
Fixatives
Formal ethanol (formaldehyde and absolute
ethanol)
Substrate
Benzedin(carcinogenic) –diaminobenzedine(DAB)
H2O2
Counterstain
Mayer’s hematoxylin
PEROXIDASE STAIN
18

PEROXIDASE STAIN :
Red –brown peroxidase found in:
neutrophil and eosinophil {promyelocyte–Myelocyte–
Metamyelocyte}
Finely granular staining found in: -Monocyte
Negative stain found in:
( early Myeloblast, lymphblast, basophiles and plasma
cell)
19

NOTES:
MPO is sensitive to light, smears
should be stained immediately
and stored in dark.
Positive control from healthy
individuals.
Overincubation: false positive
peroxides in RBCs.
20

Myeloperoxidase (MPO)
bluish-black granules red brown precipitate
21

Myeloperoxidase stain, bone marrow
aspirate
The red granular staining
peroxidase activity.
22

Leukocyte alkaline phosphatase stain
The leukocyte alkaline phosphatase (LAP) stain is helpful in
determining whether a high peripheral blood leukocytosis is a
reactive process or a leukemia (chronic myelogenous leukemia, or
CML).
The more differentiated cells in the reactive process will stain
more readily with LAP, while leukemic cells will not.
The cells on a smear can be assessed and an "LAP score" can be
generated. A high score generally indicates a "leukemoidreaction"
or reactive condition(with an infection or other inflammatory
process) while a low score suggests CML.
Purpose:
23

Leukocyte Alkaline phosphates (LAP)
Neutrophil Alkaline phosphates (NAP)
Principle:
Alkalinephosphatasewithinneutrophilshydrolyzed
naphtholASphosphate.Hydrolyzedsubstratecouples
withdye(fastblueBBsalt),pptatsiteofenzyme
activity.Degreeofstainingisproportionalto
enzymaticactivity.
Result:
The reaction product is blue and granular
24

Sampling:
Leukocyte Alkaline phosphates (LAP)
Peripheral blood
Fresh sample
Heparinized or capillary blood sample
(EDTA inhibits LAP)
If count below 5,000/cmm, use buffy
coat
25

Reagents
Fixatives
4% formalin methanol.
Substrate
Naphthol AS phosphate alkaline solution.
Fast blue BB salt or fast violet B salt.
Counterstain
Neutral red.
Leukocyte Alkaline phosphates (LAP)
26

Leukocyte Alkaline phosphates
(LAP)
Interpretation:
Count 100 neutrophils and score them (0/+4), then calculate the
final score by adding the total scores.
Grading (LAP scoring):
(0)Nostain
(+1)Faintstain
(+2)Moderatestain
(+3) Strong stain
(+4) Strong stain without cytoplasmic background
Normal Range: 30-185
27

Leukocyte Alkaline phosphatase (LAP)
Positive LAP reaction
Negative LAP reaction
28

29

N.B
Leukocyte Alkaline phosphatase (LAP)
Thin smears or thick smears may falsely elevate
results.
Only segmented or bands are scored.
Fresh samples as enzyme activity decreases and
slides should be scored as quick as possible, as the
dye tends to fade.
Eosinophils are negative but could be mistaken and
counted in the score.
30

LAP decreased in:LAP elevated in:
CML.Leukomoid reaction.
Paroxymal Nocturnal
Hemoglobinuria.
Pregnancy
Sickle cell anemia.Polycythemia vera.
Hypophosphatasia.Aplastic anemia.
Multiuple myeloma
Obstructive juindice.
Hodgkins` disease.
31

Acid phosphatase ( with tartrate resistance)
Like NAP but at pH (5)
Purpose:diagnosis of hairy cell leukemia.
32

Acid phosphatase
Principle: ACP enzyme present in white cells hydrolyzed the
substrate naphthol AS-BI phosphoric acid. Hydrolyzed.
Substrates couples with Diazo dye with ppt. at the site of
enzymatic activity.
Result:
The reaction product is red granules
33

Acid phosphatase ( with tartrate resistance)
Principle:
ACP enzyme present in white cells hydrolyzed the
substrate naphthol AS-BI phosphoric acid.
Hydrolyzed substrate couples with Diazo dye with
ppt. at the site of enzymatic activity.
Has 7 isoenzymes.
Tartaric acid inhibits all AP isoenzymes except 5
that are present only in HCL. 34

Reagents
Fixatives
Methanol + acetone.
Substrate
Naphthol AS-BI phosphate.
Fast blue BB salt or fast violet B salt.
Counterstain
Methyl green or hematoxylin.
Acid phosphatase
35

Acid phosphates
(with tartrate resistance)
Hairy cell leukemia, TRAP stain. Acid
phosphatase reaction after incubation
with tartaric acid. Granular staining is
seen in the lymphocytes.
36

Specific
estrase
(SE)
•Glucoacetate esterase
•>> granulocytic lineage
Non-specific
esterase
(NSE)
•αnaphthol acetate eatrase
•αnaphthol butyrate esterase
•naphthol AS-D esterase
•naphthol AS esterase
>> monocyticlineage
Estrases
37

Group of hydrolases
9 isoenzymes
Estrases
38

Specificestrases(1,2,7,8,9) of granulocytes
staining specifically with substrate Naphthol
AS-D chloroacetate, estrase.
NOT inhibited by Sodium fluoride.
Estrases
39

Non specificestrases(3,4,5,6) act on many
substrates
αnaphthol acetate (ANAE)
αnaphthol butyrate (ANBE)
Naphthol AS-D acetate (NASDA)
Naphthol AS acetate (NASA)
NSE of monotypes, megakaryocytes and playelets.
NSE are inhibited by Sodium fluoride.
Estrases
40

Principle:
Specific esterase or chloroacetate
Result:
The reaction product is blue black granules
41

Reagents
Fixatives
Buffered formalin acetone.
Substrate
Naphthol AS-D chloroacetate.
+
New Fuchsin(or fast blue BB).
Counterstain
Hematoxylin.
Specific esterase or chloroacetate
42

Specific esterase or chloroacetate
43

Principle:
Result:
The reaction product is orange red granules
Non Specific Esterase:
{with fluoride inhibition}
Differentiate myelocyticand monocyticleukemia.
Purpose:
44

NSEs α-naphthylacetate positivity in M5b.
Note the granular positivity in the monoblastsand immature monocytes
Non Specific Esterase
45

Interpretation
(+ve) brick –red staining which found in:
Megakaryocyte and platelets, Histocyte,
Macrophage, Monocyte & Lymphoblast of ALL
(-ve) for granulocytes
If fluoride added, only monocyte non specific
esterase will be inhibited.
46

47

48